Literature DB >> 14564629

The influence of feeding on gastric acid suppression in Helicobacter pylori-positive patients treated with a proton pump inhibitor or an H2-receptor antagonist after bleeding from a gastric ulcer.

Tatsuo Ozawa1, Nozomi Yoshikawa, Takashige Tomita, Yasushi Akita, Keiji Mitamura.   

Abstract

BACKGROUND: This study investigated the influence of feeding on gastric acid suppression in Helicobacter pylori-positive patients treated with intravenous infusions of proton pump inhibitors (PPIs) or with H2-receptor antagonists (H2-RAs) after bleeding from a gastric ulcer.
METHODS: Forty-nine H. pylori-positive patients with bleeding gastric ulcers (44 men and 5 women) were divided into four groups: one group received an H2-RA while fasting, one group received an H2-RA while eating regularly, one group received a PPI while fasting, and one group received a PPI while eating regularly. Intragastric pH was monitored during fasting and nonfasting to calculate the pH 3 and pH 4 holding times and the mean pH.
RESULTS: During a 24-h fast, the pH 3 and pH 4 holding times and the mean pH were significantly higher in patients administered omeprazole (PPI; 93.2 +/- 9.2%, 90.6 +/- 11.1%, and 6.9 +/- 0.6, respectively) than in those administered ranitidine (H2-RA; 61.0 +/- 27.5%, 55.8 +/- 29.1%, and 4.8 +/- 1.3, respectively; P<0.001 for all). Results were similar during feeding (PPI meal, 98.9 +/- 2.6%, 98.3 +/- 3.7%, and 6.9 +/- 0.3; H2-RA meal, 59.8 +/- 17.6%, 49.7 +/- 18.0%, and 4.3 +/- 0.7, respectively; P<0.001 for all). In addition, the pH 3 and pH 4 holding times and the mean pH in the H2-RA meal group were not significantly lower than those in the H2-RA group (P=0.999, P=0.865, and P=0.687, respectively). The values in the PPI and PPI meal groups were similar (P=0.872, P=0.777, and P>0.999, respectively).
CONCLUSIONS: Gastric acid suppression during the administration of an H2-RA or a PPI soon after the cessation of gastric bleeding was scarcely affected by feeding. It may well be that H. pylori-positive patients with bleeding gastric ulcer can resume a regular diet and return to work soon after bleeding ceases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14564629     DOI: 10.1007/s00535-003-1159-y

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  5 in total

Review 1.  Effects of preoperative proton pump inhibitor administration on bleeding after gastric endoscopic submucosal dissection: A systematic review and meta-analysis.

Authors:  Toshihiro Nishizawa; Hidekazu Suzuki; Teppei Akimoto; Tadateru Maehata; Toshio Morizane; Takanori Kanai; Naohisa Yahagi
Journal:  United European Gastroenterol J       Date:  2015-06-09       Impact factor: 4.623

2.  A multicenter survey of the management after gastric endoscopic submucosal dissection related to postoperative bleeding.

Authors:  Osamu Goto; Mitsuhiro Fujishiro; Ichiro Oda; Naomi Kakushima; Yorimasa Yamamoto; Yosuke Tsuji; Ken Ohata; Takashi Fujiwara; Junko Fujiwara; Naoki Ishii; Chizu Yokoi; Shinichi Miyamoto; Toshiyuki Itoh; Shinji Morishita; Takuji Gotoda; Kazuhiko Koike
Journal:  Dig Dis Sci       Date:  2011-09-08       Impact factor: 3.199

3.  Quantitative Genetics of Food Intake in Drosophila melanogaster.

Authors:  Megan E Garlapow; Wen Huang; Michael T Yarboro; Kara R Peterson; Trudy F C Mackay
Journal:  PLoS One       Date:  2015-09-16       Impact factor: 3.240

Review 4.  Early enteral nutrition versus delayed enteral nutrition in patients with gastrointestinal bleeding: A PRISMA-compliant meta-analysis.

Authors:  Hongyan Zhang; Yu Wang; Shujun Sun; Xin Huang; Guangjie Tu; Jingxu Wang; Yun Lin; Haifa Xia; Yin Yuan; Shanglong Yao
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.817

Review 5.  Histamine2-Receptor Antagonists, Proton Pump Inhibitors, or Potassium-Competitive Acid Blockers Preventing Delayed Bleeding After Endoscopic Submucosal Dissection: A Meta-Analysis.

Authors:  Xin Jiang; Jiahao Li; Jingmei Xie; Zhuoru Liang; Ning Wan; Jie Jiang; Tiantian Zhang; Yingyu Wu
Journal:  Front Pharmacol       Date:  2019-09-19       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.